Accelr8 Technology Corporation (AXK) and Denver Health Notified by Department of Defense for Rapid Diagnostics Award  
5/15/2012 10:26:23 AM

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (NYSE MKT: AXK) and Denver Health received notice that the Defense Medical Research and Development Program (DMRDP) recommended $2 million funding of a proposed 35-month project submitted jointly by Denver Health and Accelr8. The DMRDP solicited proposals to “advance state-of-the-art solutions for world-class medical care.”